Posted On: 03/16/2015 3:36:58 PM
Post# of 30015
![Avatar](https://investorshangout.com/images/ProfileImages/1666320365_13070_Warp.png)
Re: biotechexpert #18350
The company doesn't need SH consent to do a proportional RS because the OS:AS ratio remains the same (proportional). Per Nevada law, they would need SH consent if they wanted to conduct a RS where this ratio changes, as was done with ADXS.
Quote:http://www.thechairmansblog.com/amarantus-bio...-strategy/
Amarantus scenario:
• Amarantus has approximately 750 million shares (fully diluted) and 2 billion shares authorized (assuming shareholder approval of the increase in authorized shares from 1 billion to 2 billion);
• The Company’s Board elects to reduce the number of outstanding shares to 37.5 million (1:20) and reduce the number of authorized shares to 100 million (1:20) – under the laws of the State of Nevada, Amarantus’ Board of Directors can only implement a proportional reduction in the outstanding shares and authorized shares without a shareholder vote;
• The new cap structure is 37.5M shares outstanding and 100M authorized.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)